[1] Takata T and Slootweg PJ. Tumours of the oral cavity and mobile tongue. Solan P, Gale N, Hunter K, Lingen M, Nylander K, Reibel J, et al. Malignant surface epithelial tumours. In: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO Classification of Head and Neck Tumours. 4th ed. Lyon: IARC; 2017. p.108- 111.
[2] Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 2009;45:309-16.
[3] Sinevici N, O'Sullivan J. Oral cancer: Deregulated molecular events and their use as biomarkers. Oral Oncol 2016;61:12-8.
[4] Omar E. Current concepts and future of noninvasive procedures for diagnosingoral squamous cell carcinoma--a systematic review. Head Face Med 2015;11:6.
[5] Reddavid R, Sofia S, Chiaro P, Colli F, Trapani R, Esposito L, et al. Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake? World J Gastroenterol 2018; 14:274-89.
[6] Miao ZF, Liu XY, Wang ZN, Zhao TT, Xu YY, Song YX, et al. Effect of neoadjuvant chemotherapy in patients with gastric cancer: a PRISMA-compliant systematic review and meta-analysis. BMC cancer 2018;31:118.
[7] Humphrey JD, Dufresne ER, Schwartz MA. Mechanotransduction and extracellular matrix homeostasis. Nat Rev Mol Cell Biol 2014;15:802-12.
[8] Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 2009;139:891-906.
[9] Dou C, Liu Z, Tu K, Zhang H, Chen C, Yaqoob U, et al. P300 Acetyltransferase mediates stiffness-induced activation of hepatic stellate cells into tumor-promoting myofibroblasts. Gastroenterology 2018;154:2209-.e14.
[10] Adapala RK, Thoppil RJ, Ghosh K, Cappelli HC, Dudley AC, Paruchuri S, et al. Activation of mechanosensitive ion channel TRPV4 normalizes tumor vasculature and improves cancer therapy. Oncogene 2016;35:314-22.
[11] Meng Z, Qiu Y, Lin KC, Kumar A, Placone JK, Fang C, et al. RAP2 mediates mechanoresponses of the Hippo pathway. Nature 2018;560:655-60.
[12] Garcia-Elias A, Mrkonjić S, Jung C, Pardo-Pastor C, Vicente R, Valverde MA. The TRPV4 channel. Handb Exp Pharmacol 2014;222:293-319.
[13] Köhler R, Heyken WT, Heinau P, Schubert R, Si H, Kacik M, et al. Evidence for a functional role of endothelial transient receptor potential V4 in shear stress-induced vasodilatation. Arterioscler Thromb Vasc Biol 2006;26:1495-502.
[14] Mendoza SA, Fang J, Gutterman DD, Wilcox DA, Bubolz AH, Li R, et al. TRPV4- mediated endothelial Ca2+ influx and vasodilation in response to shear stress. Am J Physiol Heart Circ Physiol 2010;298:H466-76.
[15] Watanabe H, Vriens J, Suh SH, Benham CD, Droogmans G, Nilius B. Heat-evoked activation of TRPV4 channels in a HEK293 cell expression system and in native mouse aorta endothelial cells. J Biol Chem 2002;277:47044-51.
[16] Liedtke W, Choe Y, Marti-Renom MA, Bell AM, Denis CS, Sali A, et al. Vanilloid receptor-related osmotically activated channel (VR-OAC), a candidate vertebrate osmoreceptor. Cell 2000;103:525-35.
[17] Xie R, Xu J, Xiao Y, Wu J, Wan H, Tang B, et al. Calcium promotes human gastric cancer via a novel coupling of calcium-sensing receptor and TRPV4 channel. Cancer Res 2017;77:6499-512.
[18] Tang B, Wu J, Zhu MX, Sun X, Liu J, Xie R, et al. VPAC1 couples with TRPV4 channel to promote calcium-dependent gastric cancer progression via a novel autocrine mechanism. Oncogene 2019;38:3946-61.
[19] Fang Y, Liu G, Xie C, Qian K, Lei X, Liu Q, et al. Pharmacological inhibition of TRPV4 channel suppresses malignant biological behavior of hepatocellular carcinoma via modulation of ERK signaling pathway. Biomed Pharmacother 2018;101:910-9.
[20] Morifuji M, Taniguchi S, Sakai H, Nakabeppu Y, Ohishi M. Differential expression of cytokeratin after orthotopic implantation of newly established human tongue cancer cell lines of defined metastatic ability. Am J Pathol 2000;156:1317-26.
[21] Kibe T, Kishida M, Kamino M, Iijima M, Chen L, Habu M, et al.Immortalization and characterization of normal oral epithelial cells without using HPV and SV40 genes. Oral Sci Int 2011;8:20-8.
[22] Kitsuki T, Yoshimoto RU, Aijima R, Hatakeyama J, Cao AL, Zhang JQ, et al. Enhanced junctional epithelial permeability in TRPV4-deficient mice. J Periodontal Res 2020;55:51-60.
[23] Matsumoto S, Fujii S, Sato A, Ibuka S, Kagawa Y, Ishii M, et al. A combination of Wnt and growth factor signaling induces Arl4c expression to form epithelial tubular structures. EMBO J 2014;33:702-18.
[24] Mikami Y, Fujii S, Nagata K, Wada H, Hasegawa K, Abe M, et al. GLI-mediated Keratin 17 expression promotes tumor cell growth through the anti-apoptotic function in oral squamous cell carcinomas. J Cancer Res Clin Oncol 2017;143:1381- 93.
[25] Takayama Y, Furue H, Tominaga M. 4-isopropylcyclohexanol has potential analgesic effects through the inhibition of anoctamin 1, TRPV1 and TRPA1 channel activities. Sci Rep 2017;7:43132.
[26] Miyoshi H, Blömer U, Takahashi M, Gage FH, Verma IM. Development of a self- inactivating lentivirus vector. J Virol 1998;72:8150-7.
[27] Fujii S, Shinjo K, Matsumoto S, Harada T, Nojima S, Sato S, et al. Epigenetic upregulation of ARL4C, due to DNA hypomethylation in the 3'-untranslated region, promotes tumorigenesis of lung squamous cell carcinoma. Oncotarget 2016;7:81571-87.
[28] Fujii S, Nagata K, Matsumoto S, Kohashi KI, Kikuchi A, Oda Y, et al. Wnt/β-catenin signaling, which is activated in odontomas, reduces Sema3A expression to regulate odontogenic epithelial cell proliferation and tooth germ development. Sci Rep 2019;9:4257.
[29] Fujii S, Matsumoto S, Nojima S, Morii E, Kikuchi A. Arl4c expression in colorectal and lung cancers promotes tumorigenesis and may represent a novel therapeutic target. Oncogene 2015;34:4834-44.
[30] Brierley JD, Gospodarowicz MK, Wittekind C. Head and Neck tumours. In: Brierley JD, Gospodarowicz MK, and Wittekind C editors. TNM classification of Malignant Tumours. 8th ed. Hoboken, NJ: Wiley Blackwell 2017. p.17-21.
[31] Mikami Y, Fujii S, Kohashi KI, Yamada Y, Moriyama M, Kawano S, et al. Low- grade myofibroblastic sarcoma arising in the tip of the tongue with intravascular invasion: A case report. Oncol Lett 2018;16:3889-94.
[32] Jie P, Hong Z, Tian Y, Li Y, Lin L, Zhou L, et al. Activation of transient receptor potential vanilloid 4 induces apoptosis in hippocampus through downregulating PI3K/Akt and upregulating p38 MAPK signaling pathways. Cell Death Dis 2015;6:e1775.
[33] Xu S, Liu B, Yin M, Koroleva M, Mastrangelo M, Ture S, et al. A novel TRPV4- specific agonist inhibits monocyte adhesion and atherosclerosis. Oncotarget 2016;7:37622-35.
[34] Lee WH, Choong LY, Jin TH, Mon NN, Chong S, Liew CS, et al. TRPV4 plays a role in breast cancer cell migration via Ca2+-dependent activation of AKT and downregulation of E-cadherin cell cortex protein. Oncogenesis 2017;6:e338.
[35] Ou-Yang Q, Li B, Xu M, Liang H. TRPV4 promotes the migration and invasion of glioma cells via AKT/Rac1 signaling. Biochem Biophys Res Commun 2018;503:876-81.
[36] Takemoto-Kimura S, Suzuki K, Horigane SI, Kamijo S, Inoue M, Sakamoto M, et al. Calmodulin kinases: essential regulators in health and disease. J Neurochem 2017;141:808-18.
[37] Perez-Garcia MJ, Cena V, de Pablo Y, LIovera M, Commella JX, Soler RM. Glial cell line-derived neurotrophic factor increases intracellular calcium concentration. Role of calcium/calmodulin in the activation of the phosphatidylinositol 3-kinase pathway. J Biol Chem 2004;279:6132-42.
[38] Lim J, Kim JH, Paeng JY, Kim MJ, Hong SD, Lee JI, et al. Prognostic value of activated Akt expression in oral squamous cell carcinoma. J Clin Pathol 2005;58:1199-205.
[39] Yu Z, Weinberger PM, Sasaki C, Egleston BL, Speier WF 4th, Haffy B, et al. Phosphorylation of Akt (Ser473) predicts poor clinical outcome in oropharyngeal squamous cell cancer. Cancer Epidemiol Biomarkers Prev 2007;16:553-8.
[40] Butcher DT, Alliston T, Weaver VM. A tense situation: forcing tumour progression. Nat Rev Cancer 2009;9:108-22.
[41] Rubashkin MG, Cassereau L, Bainer R, DuFort CC, Yui Y, Ou G, et al. Force engages vinculin and promotes tumor progression by enhancing PI3K activation of phosphatidylinositol (3,4,5)-triphosphate. Cancer Res 2014;74:4597-611.
[42] Paszek MJ, Zahir N, Johnson KR, Lakins JN, Rozenberg GI, Gefen A, et al. Tensional homeostasis and the malignant phenotype. Cancer Cell 2005;8:24154.
[43] Thodeti CK, Matthews B, Ravi A, Mammoto A, Ghosh K, Bracha AL, et al.TRPV4 channels mediate cyclic strain-induced endothelial cell reorientation through integrin-to-integrin signaling. Circ Res 2009;104:1123-30.
[44] The Cancer Genome Atlas Network. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 2015;517:576-82
[45] Hasegawa K, Fujii S, Matsumoto S, Tajiri Y, Kikuchi A, Kiyoshima T. YAP signaling induces PIEZO1 expression to promote oral squamous cell carcinoma cell proliferation. J Pathol 2021;253:80-93.
論文の公開元へ
